Y. Goshen

538 total citations
25 papers, 400 citations indexed

About

Y. Goshen is a scholar working on Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Y. Goshen has authored 25 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Public Health, Environmental and Occupational Health and 5 papers in Oncology. Recurrent topics in Y. Goshen's work include Acute Lymphoblastic Leukemia research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Y. Goshen is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Sarcoma Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Y. Goshen collaborates with scholars based in Israel, France and United States. Y. Goshen's co-authors include Isaac Yaniv, Rina Zaizov, Jerry Stein, Ian J. Cohen, Doron Carmi, Shlomit Shalitin, Moshe Phillip, Smadar Avigad, Batia Stark and Liora Kornreich and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Oncogene.

In The Last Decade

Y. Goshen

24 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y. Goshen Israel 12 109 108 85 77 75 25 400
Pierluigi Marradi Italy 12 103 0.9× 74 0.7× 91 1.1× 53 0.7× 41 0.5× 22 377
James S. Roloff United States 10 73 0.7× 121 1.1× 43 0.5× 40 0.5× 78 1.0× 15 447
P. Kajtár Hungary 11 48 0.4× 96 0.9× 62 0.7× 77 1.0× 39 0.5× 30 304
M O'Brien United States 10 118 1.1× 199 1.8× 112 1.3× 95 1.2× 76 1.0× 12 542
Pedro A. deAlarcon United States 5 106 1.0× 33 0.3× 57 0.7× 106 1.4× 50 0.7× 8 446
U. Kluba Germany 7 126 1.2× 101 0.9× 71 0.8× 72 0.9× 28 0.4× 13 315
Constance Danielson United States 7 156 1.4× 50 0.5× 50 0.6× 34 0.4× 67 0.9× 16 338
Halil Gürhan Karabulut Türkiye 11 85 0.8× 130 1.2× 28 0.3× 44 0.6× 43 0.6× 42 369
Te‐Kau Chang Taiwan 12 98 0.9× 77 0.7× 24 0.3× 25 0.3× 38 0.5× 26 298
Brigitta Rumberger Germany 9 61 0.6× 178 1.6× 172 2.0× 96 1.2× 48 0.6× 10 480

Countries citing papers authored by Y. Goshen

Since Specialization
Citations

This map shows the geographic impact of Y. Goshen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Goshen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Goshen more than expected).

Fields of papers citing papers by Y. Goshen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Goshen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Goshen. The network helps show where Y. Goshen may publish in the future.

Co-authorship network of co-authors of Y. Goshen

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Goshen. A scholar is included among the top collaborators of Y. Goshen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Goshen. Y. Goshen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yovel, Galit, et al.. (2010). Dissociating between the role of exposure and individuation in perceptual expertise for faces. Journal of Vision. 9(8). 458–458. 1 indexed citations
2.
Shalitin, Shlomit, Moshe Phillip, Jerry Stein, et al.. (2006). Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplantation. 37(12). 1109–1117. 74 indexed citations
3.
Ohali, Anat, Smadar Avigad, Ian J. Cohen, et al.. (2005). The clinical relevance of telomerase activity and telomere length in pediatric solid tumors. Journal of Clinical Oncology. 23(16_suppl). 8547–8547. 1 indexed citations
4.
Liberzon, Ella, Smadar Avigad, Isaac Yaniv, et al.. (2004). Molecular variants of the ATM gene in Hodgkin's disease in children. British Journal of Cancer. 90(2). 522–525. 15 indexed citations
5.
Cohen, Ian J., Shifra Ash, Y. Goshen, et al.. (2004). The impact of treatment for osteosarcoma on long term survivors with therapy of increasing dosage and dose intensity. Journal of Clinical Oncology. 22(14_suppl). 8571–8571. 1 indexed citations
6.
Armoni, Michal, Michael J. Quon, Gila Maor, et al.. (2002). PAX3/Forkhead Homolog in Rhabdomyosarcoma Oncoprotein Activates Glucose Transporter 4 Gene Expressionin Vivoandin Vitro. The Journal of Clinical Endocrinology & Metabolism. 87(11). 5312–5324. 30 indexed citations
7.
Mor, Celia, et al.. (2000). Improved outcome in childhood B-cell lymphoma with the intensified French LMB protocol. Medical and Pediatric Oncology. 35(1). 8–12. 16 indexed citations
8.
Shemesh, Eyal, Isaac Yaniv, M. Drucker, et al.. (1998). Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Medical and Pediatric Oncology. 30(2). 95–100. 26 indexed citations
9.
Stark, Batia, Celia Mor, Marta Jeison, et al.. (1997). Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors. Journal of Neuro-Oncology. 31(1-2). 3–8. 16 indexed citations
10.
Avigad, Smadar, Meira Zoldan, Celia Mor, et al.. (1997). A novel germ line p53 mutation in intron 6 in diverse childhood malignancies. Oncogene. 14(13). 1541–1545. 36 indexed citations
11.
Yaniv, Isaac, Antoine M. Saab, Ian J. Cohen, et al.. (1996). Hodgkin Disease in Children. Journal of Pediatric Hematology/Oncology. 18(1). 76–80. 14 indexed citations
12.
Kornreich, Liora, Y. Goshen, Gadi Horev, & Michael F. Grunebaum. (1995). Mycobacterial respiratory infection in leukemic children. European Journal of Radiology. 21(1). 44–46. 7 indexed citations
13.
Galactéros, Frédéric, Janice E Martin, Michel Goossens, et al.. (1994). Hb Taybe (alpha 38 or 39 THR deleted): an alpha-globin defect, silent in the heterozygous state and producing severe hemolytic anemia in the homozygous.. PubMed. 317(5). 437–44. 18 indexed citations
14.
Tamary, Hannah, et al.. (1994). Chronic childhood idiopathic thrombocytopenia purpura: long‐term follow‐up. Acta Paediatrica. 83(9). 931–934. 35 indexed citations
15.
Cohen, Ian J., Chaim Kaplinsky, Karol H. Katz, et al.. (1993). Improved results in osteogenic sarcoma 1973-79 vs. 1980-86: analysis of results from a single center.. PubMed. 29(1). 27–9. 4 indexed citations
16.
Kaplinsky, Chaim, Y. Goshen, David Loven, et al.. (1993). Hodgkin's disease in children—Reduced tailored chemotherapy for stage I–II disease. European Journal of Cancer. 29. S170–S170. 1 indexed citations
17.
Kaplinsky, Chaim, et al.. (1988). Deferoxamine (Desferal)R—Induced Ocular Toxicity. Pediatric Hematology and Oncology. 5(4). 293–297. 5 indexed citations
18.
Kaplinsky, Chaim, et al.. (1988). Eosinophilic Granulomatous Lymphadenopathy: Association with Hyper-IgE and Eosinophilia. Pediatric Pathology. 8(4). 377–384. 1 indexed citations
19.
Shalmon, Lea, et al.. (1987). [Genetic characterization of sickle-cell anemia in Israeli Arabs].. PubMed. 113(9). 201–4.
20.
Koren, Andrew, et al.. (1983). [Postsplenectomy sepsis in children].. PubMed. 105(9). 252–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierluigi Marradi Breakdown of academic impact, for papers by James S. Roloff Breakdown of academic impact, for papers by P. Kajtár Breakdown of academic impact, for papers by M O'Brien Breakdown of academic impact, for papers by Pedro A. deAlarcon Breakdown of academic impact, for papers by U. Kluba Breakdown of academic impact, for papers by Constance Danielson Breakdown of academic impact, for papers by Halil Gürhan Karabulut Breakdown of academic impact, for papers by Te‐Kau Chang Breakdown of academic impact, for papers by Brigitta Rumberger
Rankless by CCL
2026